HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation.

AbstractINTRODUCTION:
Letermovir is a new antiviral approved to prevent cytomegalovirus infection in hematopoietic stem cell transplant recipients. It has a distinct mechanism of action as it acts as a terminase complex inhibitor, and shows some advantages compared to the current treatment options for cytomegalovirus infection. Areas covered: This review focuses on the efficacy, safety, pharmacokinetics, pharmacodynamics, and drug-drug interactions of letermovir. Expert opinion: Letermovir is a new antiviral to prevent cytomegalovirus infection. Unlike the currently used polymerase inhibitors, it has a distinct mechanism of action with better safety, limited resistance, and no cross-resistance. Although a lot of research on pharmacokinetics and drug-drug interactions has already been performed, it might be useful to clarify the effect of letermovir on voriconazole exposure, the drug-drug interaction between caspofungine and letermovir and the effect of statins on letermovir exposure. Also, the lack of an exposure-response relationship should be confirmed in large real-life post-marketing studies in order to be able to lower the intravenous dose of letermovir.
AuthorsBarbara Deleenheer, Isabel Spriet, Johan Maertens
JournalExpert opinion on drug metabolism & toxicology (Expert Opin Drug Metab Toxicol) Vol. 14 Issue 12 Pg. 1197-1207 (Dec 2018) ISSN: 1744-7607 [Electronic] England
PMID30479172 (Publication Type: Journal Article, Review)
Chemical References
  • Acetates
  • Antiviral Agents
  • Quinazolines
  • letermovir
Topics
  • Acetates (administration & dosage, pharmacokinetics, pharmacology)
  • Antiviral Agents (administration & dosage, pharmacokinetics, pharmacology)
  • Cytomegalovirus
  • Cytomegalovirus Infections (etiology, prevention & control)
  • Drug Interactions
  • Drug Resistance, Viral
  • Hematopoietic Stem Cell Transplantation (methods)
  • Humans
  • Quinazolines (administration & dosage, pharmacokinetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: